Lobbying Activity Report

6452-53889

Designated Filer name: Gerry Jeffcott
Client: The Canadian Forum for Rare Disease Innovators (RAREi)
Would you like to identify any other entity with a direct interest in the outcome of this lobbying activity that worked together for the purpose of lobbying on any or all of the listed lobbying topics? Yes
Lobbying activity performed with and/or on behalf of the following other entities with a direct interest in the outcome of the lobbying activity that worked together for the purpose of performing this lobbying activity: Alexion Pharma Canada Corp.
Biogen Canada
Vertex Pharmaceuticals (Canada) Inc.
Associated registration: 11976-6452-2
Lobbying Activity date: 2026-08-25
Arranged a meeting: Yes
Posted date: 2026-08-26

Senior Public Office Holders who were lobbied in this activity: Anna Kindy, MLA for North Island
Member(s) of the BC Legislative Assembly
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Provincial expensive drugs for rare disease program review and other rare disease-related policy issues
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Economic Development and Trade, Emergency Preparedness, Finances and Budgets, Health, Hospitals, Industry, Intellectual Property, International Trade, Mental Health and Addictions, Science and Technology
Date Modified: